OptiScan Stock

optiscancorp.comHealthcareFounded: 1900Funding to Date: $207.05MM

Optiscan Biomedical is the developer of a monitoring platform for use in hospital intensive care units (ICUs) to support clinicians in detecting changes more rapidly in critically ill patients, enabling more timely intervention.

Register for Details

For more details on financing and valuation for OptiScan, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for OptiScan.

Register Today

Team

Management Team

Carlo Mata
Director of Marketing
Patrick Nugent
Chief Financial Officer
Cary Vance
Chief Executive Officer, President & Board Member
Jim Causey
Vice President, Research & Development

Board Members

Paul Mieyal Ph.D
Wexford Capital
Phillip Stern
Chartline Capital Partners
Kenneth Abramowitz
NGN Capital
Aditya Puri
Xeraya Capital
Charles Liamos
MedVenture Associates

Other companies like OptiScan in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$885.01MM

News

OptiScan Biomedical Announces Peer-Reviewed Publications Highlighting First-of-its-Kind Continuous Monitoring Platform for Intensive Care Units - read this article along with other careers information, tips and advice on BioSpace
OptiScan Biomedical, a developer of an innovative continuous monitoring system for use in the surgical intensive care unit, closed $20m Series E financing
OptiScan Biomedical said today that it closed a $20 million Series E round to support the commercialization of its continuous monitoring system, the OptiScanner 5000, in the U.S. The company’s device is an automated bedside blood glucose monitor designed for use in the intensive care unit. The system can measure glucose values from a micro-sample of […]